Future Scope of Antibiotic Resistance Biomarkers Industry

Future Scope of Antibiotic Resistance Biomarkers Industry

Antimicrobial resistance (AMR) occurs when microbes develop mechanisms that protect them from the effects of antimicrobial agents. The term antibiotic resistance is a subset of the AMR as it refers to bacteria that become resistant to antibiotics. Resistant microbes are more difficult to treat and require higher doses or alternative drugs, which can prove more toxic.

Get Sample PDF


Some of the key players of Antibiotic Resistance Biomarkers Industry:

Thermo Fisher Scientific, Qiagen, Abbott, Bio-Rad Laboratories, Cube Dx GmbH, GenMark Diagnostic, Merck, Creative Diagnostic, Roche, HiMedia Laboratories, Danaher Corporatory

These approaches can also be more expensive. Microbes that are resistant to multiple antimicrobial agents are known as multi-resistant (MDR). All classes of microbes can develop resistance. Fungi develop an antifungal resistance. Viruses develop antiviral resistance. Protozoa develop resistance to protozoa and bacteria develop resistance to antibiotics. Those bacteria that are considered largely drug resistant (XDR) or fully drug resistant (TDR) are sometimes referred to as "superbugs".

Resistance in bacteria can arise naturally, through genetic mutation, or when one species acquires resistance from another. Resistance can arise spontaneously due to random mutations. However, the expanded use of antimicrobial agents appears to encourage the selection of mutations that can render antimicrobial agents ineffective.

Comments

Popular posts from this blog

Cystoscope Market Estimate to Boost Growth in Demand by 2027 with Top Key Players: Henke-Sass Wolf, Olympus Corporation, Stryker, NeoScope Inc., KARL STORZ SE & Co. KG

Future Scope for Deep Sea Exploration Robot Industry

Huge Demand for Weather Radar Industry